However, InvestingPro analysis shows that ICON generally trades with low ... Ongoing market volatility, particularly in the biotech sector, poses a significant risk to ICON’s business model.
Icon (ICLR – Research Report) received a Hold rating and price target from Goldman Sachs analyst Matthew Sykes today. The company’s shares ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback